These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 31646336

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. PU.1 downregulation in murine radiation-induced acute myeloid leukaemia (AML): from molecular mechanism to human AML.
    Verbiest T, Bouffler S, Nutt SL, Badie C.
    Carcinogenesis; 2015 Apr; 36(4):413-9. PubMed ID: 25750172
    [Abstract] [Full Text] [Related]

  • 3. Influence of radiation quality on mouse chromosome 2 deletions in radiation-induced acute myeloid leukaemia.
    Brown N, Finnon R, Manning G, Bouffler S, Badie C.
    Mutat Res Genet Toxicol Environ Mutagen; 2015 Nov; 793():48-54. PubMed ID: 26520372
    [Abstract] [Full Text] [Related]

  • 4. Sfpi1/PU.1 mutations in mouse radiation-induced acute myeloid leukaemias affect mRNA and protein abundance and associate with disrupted transcription.
    Brown NL, Finnon R, Bulman RA, Finnon P, Moody J, Bouffler SD, Badie C.
    Leuk Res; 2011 Jan; 35(1):126-32. PubMed ID: 20638124
    [Abstract] [Full Text] [Related]

  • 5. Live cell detection of chromosome 2 deletion and Sfpi1/PU1 loss in radiation-induced mouse acute myeloid leukaemia.
    Olme CH, Finnon R, Brown N, Kabacik S, Bouffler SD, Badie C.
    Leuk Res; 2013 Oct; 37(10):1374-82. PubMed ID: 23806234
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Dose-Rate-Dependent PU.1 Inactivation to Develop Acute Myeloid Leukemia in Mice Through Persistent Stem Cell Proliferation After Acute or Chronic Gamma Irradiation.
    Ojima M, Hirouchi T, Etani R, Ariyoshi K, Fujishima Y, Kai M.
    Radiat Res; 2019 Dec; 192(6):612-620. PubMed ID: 31560640
    [Abstract] [Full Text] [Related]

  • 8. Molecular characterisation of murine acute myeloid leukaemia induced by 56Fe ion and 137Cs gamma ray irradiation.
    Steffen LS, Bacher JW, Peng Y, Le PN, Ding LH, Genik PC, Ray FA, Bedford JS, Fallgren CM, Bailey SM, Ullrich RL, Weil MM, Story MD.
    Mutagenesis; 2013 Jan; 28(1):71-9. PubMed ID: 22987027
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Inverse correlation between Flt3 and PU.1 expression in acute myeloblastic leukemias.
    Inomata M, Takahashi S, Harigae H, Kameoka J, Kaku M, Sasaki T.
    Leuk Res; 2006 Jun; 30(6):659-64. PubMed ID: 16271760
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. PU.1 promotes cell cycle exit in the murine myeloid lineage associated with downregulation of E2F1.
    Ziliotto R, Gruca MR, Podder S, Noel G, Ogle CK, Hess DA, DeKoter RP.
    Exp Hematol; 2014 Mar; 42(3):204-217.e1. PubMed ID: 24316397
    [Abstract] [Full Text] [Related]

  • 15. Vav1 is necessary for PU.1 mediated upmodulation of miR-29b in acute myeloid leukaemia-derived cells.
    Vezzali F, Grassilli S, Lambertini E, Brugnoli F, Patergnani S, Nika E, Piva R, Pinton P, Capitani S, Bertagnolo V.
    J Cell Mol Med; 2018 Jun; 22(6):3149-3158. PubMed ID: 29532991
    [Abstract] [Full Text] [Related]

  • 16. Sox4 cooperates with PU.1 haploinsufficiency in murine myeloid leukemia.
    Aue G, Du Y, Cleveland SM, Smith SB, Davé UP, Liu D, Weniger MA, Metais JY, Jenkins NA, Copeland NG, Dunbar CE.
    Blood; 2011 Oct 27; 118(17):4674-81. PubMed ID: 21878674
    [Abstract] [Full Text] [Related]

  • 17. Hyper-radiosensitivity affects low-dose acute myeloid leukemia incidence in a mathematical model.
    Stouten S, Balkenende B, Roobol L, Lunel SV, Badie C, Dekkers F.
    Radiat Environ Biophys; 2022 Aug 27; 61(3):361-373. PubMed ID: 35864346
    [Abstract] [Full Text] [Related]

  • 18. Essential role of Jun family transcription factors in PU.1 knockdown-induced leukemic stem cells.
    Steidl U, Rosenbauer F, Verhaak RG, Gu X, Ebralidze A, Otu HH, Klippel S, Steidl C, Bruns I, Costa DB, Wagner K, Aivado M, Kobbe G, Valk PJ, Passegué E, Libermann TA, Delwel R, Tenen DG.
    Nat Genet; 2006 Nov 27; 38(11):1269-77. PubMed ID: 17041602
    [Abstract] [Full Text] [Related]

  • 19. USP22 deficiency leads to myeloid leukemia upon oncogenic Kras activation through a PU.1-dependent mechanism.
    Melo-Cardenas J, Xu Y, Wei J, Tan C, Kong S, Gao B, Montauti E, Kirsammer G, Licht JD, Yu J, Ji P, Crispino JD, Fang D.
    Blood; 2018 Jul 26; 132(4):423-434. PubMed ID: 29844011
    [Abstract] [Full Text] [Related]

  • 20. Down-regulation of Notch-1 expression decreases PU.1-mediated myeloid differentiation signaling in acute myeloid leukemia.
    Chen PM, Yen CC, Wang WS, Lin YJ, Chu CJ, Chiou TJ, Liu JH, Yang MH.
    Int J Oncol; 2008 Jun 26; 32(6):1335-41. PubMed ID: 18497996
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.